bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
4.090
-0.250 (-5.76%)
Apr 23, 2025, 4:00 PM EDT - Market closed
bluebird bio Market Cap
bluebird bio has a market cap or net worth of $40.04 million as of April 24, 2025. Its market cap has decreased by -68.42% in one year.
Market Cap
40.04M
Enterprise Value
348.26M
1-Year Change
-68.42%
Ranking
Category
Stock Price
$4.09
Market Cap Chart
Since June 19, 2013, bluebird bio's market cap has decreased from $588.50M to $40.04M, a decrease of -93.20%. That is a compound annual growth rate of -20.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 40.00M | -50.68% |
| Dec 31, 2024 | 81.10M | -46.26% |
| Dec 29, 2023 | 150.90M | -73.70% |
| Dec 30, 2022 | 573.70M | -18.09% |
| Dec 31, 2021 | 700.40M | -75.61% |
| Dec 31, 2020 | 2.87B | -40.85% |
| Dec 31, 2019 | 4.86B | -10.51% |
| Dec 31, 2018 | 5.43B | -33.53% |
| Dec 29, 2017 | 8.16B | 254.64% |
| Dec 30, 2016 | 2.30B | -2.28% |
| Dec 31, 2015 | 2.36B | -10.90% |
| Dec 31, 2014 | 2.64B | 429.89% |
| Dec 31, 2013 | 498.90M | -15.23% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.45B |
| UnitedHealth Group | 384.25B |
| Johnson & Johnson | 378.11B |
| AbbVie | 305.68B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 226.75B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |